The Heart Institute, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Neufeld Cardiac Research Institute, Sheba Medical Center, Ramat Gan, Israel.
Clin Cardiol. 2021 Jun;44(6):748-753. doi: 10.1002/clc.23652. Epub 2021 May 26.
Current evidence regarding the optimal length of hospital stay (LOS) following myocardial infarction (MI) is limited. This study aimed to examine LOS policy for MI patients and to assess the safety of early discharge.
A prospective observational study that included patients with STEMI and NSTEMI enrolled in the Acute Coronary Syndrome Israeli Survey (ACSIS) during the years 2000-2016. Patients were divided into three subgroups according to their LOS: <3 days (short-LOS), 3-6 days (intermediate-LOS) and >6 days (long-LOS). We compared baseline characteristics, management strategies and clinical outcomes at 30 days and 1 year in these groups.
Ten thousand four hundred and fifty eight patients were enrolled in the study. The LOS of MI patients gradually decreased over time. Short-LOS and intermediate-LOS patients had similar clinical characteristics while patients in the long-LOS group were older with more co-morbidity. There was no difference in the clinical outcomes, including re-MI, arrhythmias, 30 days MACE, and 30 days mortality between the short-LOS and intermediate-LOS groups. However, the rate of re-hospitalizations was higher in the short-LOS group (20.9% vs. 17.8%, p = .004) without evidence of increased cardiovascular events. In multivariate analysis, the LOS did not predict either 30 days mortality (HR: 1.3; CI:0.45-5.48), nor MACE at 30 days (HR: 1.1; CI:0.79-1.56).
Our study suggests that an early discharge strategy of up to 3 days from admission is safe for low and intermediate-risk patients after both STEMI and NSTEMI. Nevertheless, this strategy is associated with an increased risk of potential avoidable readmission and there might be psychological and social factors that may warrant a longer stay.
目前关于心肌梗死(MI)后住院时间(LOS)的最佳长度的证据有限。本研究旨在检查 MI 患者的 LOS 政策,并评估早期出院的安全性。
一项前瞻性观察性研究,纳入了 2000 年至 2016 年期间在急性冠状动脉综合征以色列调查(ACSIS)中登记的 STEMI 和 NSTEMI 患者。患者根据 LOS 分为三组:<3 天(短 LOS)、3-6 天(中 LOS)和>6 天(长 LOS)。我们比较了这些组在 30 天和 1 年时的基线特征、管理策略和临床结局。
本研究共纳入 10458 例患者。MI 患者的 LOS 逐渐减少。短 LOS 和中 LOS 患者的临床特征相似,而长 LOS 组的患者年龄较大,合并症较多。短 LOS 和中 LOS 组之间在再心肌梗死、心律失常、30 天 MACE 和 30 天死亡率等临床结局方面没有差异。然而,短 LOS 组的再住院率较高(20.9% vs. 17.8%,p=0.004),但心血管事件发生率并未增加。多变量分析显示,LOS 既不能预测 30 天死亡率(HR:1.3;95%CI:0.45-5.48),也不能预测 30 天 MACE(HR:1.1;95%CI:0.79-1.56)。
我们的研究表明,对于 STEMI 和 NSTEMI 后低危和中危患者,入院后 3 天内的早期出院策略是安全的。然而,这种策略与潜在可避免的再入院风险增加有关,可能存在心理和社会因素,需要更长的住院时间。